rs2069561
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003235.5(TG):c.5512G>A(p.Asp1838Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 1,613,286 control chromosomes in the GnomAD database, including 210,810 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003235.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TG | NM_003235.5 | c.5512G>A | p.Asp1838Asn | missense_variant | 29/48 | ENST00000220616.9 | NP_003226.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TG | ENST00000220616.9 | c.5512G>A | p.Asp1838Asn | missense_variant | 29/48 | 1 | NM_003235.5 | ENSP00000220616 | P1 | |
TG | ENST00000518058.1 | c.46G>A | p.Asp16Asn | missense_variant | 1/2 | 1 | ENSP00000429164 | |||
TG | ENST00000523756.5 | c.*1725G>A | 3_prime_UTR_variant, NMD_transcript_variant | 16/35 | 1 | ENSP00000428628 | ||||
TG | ENST00000519178.5 | c.880G>A | p.Asp294Asn | missense_variant | 8/27 | 2 | ENSP00000430523 |
Frequencies
GnomAD3 genomes AF: 0.402 AC: 60999AN: 151890Hom.: 14938 Cov.: 32
GnomAD3 exomes AF: 0.495 AC: 124497AN: 251260Hom.: 32989 AF XY: 0.499 AC XY: 67688AN XY: 135776
GnomAD4 exome AF: 0.511 AC: 747173AN: 1461278Hom.: 195871 Cov.: 52 AF XY: 0.511 AC XY: 371710AN XY: 726978
GnomAD4 genome AF: 0.401 AC: 60995AN: 152008Hom.: 14939 Cov.: 32 AF XY: 0.406 AC XY: 30180AN XY: 74296
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 08, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Iodotyrosyl coupling defect Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at